USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Critical Care Antibiotics Markets
U.S. Critical Care Antibiotics Markets
RELEASE DATE
05-May-2003
05-May-2003
REGION
North America
North America
Research Code: A443-01-00-00-00
SKU: HC00884-NA-MR_04654
$3,950.00
Special Price $2,962.50 save 25 %
In stock
SKU
HC00884-NA-MR_04654
Description
The U.S. Critical Care Antibiotics Markets report covers the various injectable antibiotics that are currently available and used in critical care in the U.S. namely, cephalosporins, quinolones, penicilliins, carbapenems and others including new classes streptogrammins and oxazolidones. The report also major pipeline critical care antibiotics. Frost & Sullivan Market Engineering Analysis, major market/technology trends, challenges, drivers and restraints and forecasts are covered on a total level and also as at the levels of the various segments. The report cites five prestigious Frost & Sullivan Market Engineering Awards to active industry participants for effective industry approaches.
Table of Contents
Executive Summary
- Executive Summary
Definitions and Classification
- Report Scope
- Infections in Critical Care Settings
- Antibiotics as Life-Sustaining Technology
- Critical Care Antibiotics
Challenges
- Expanding Resistant Strains
- More Stringent Treatment Guidelines
- Increasing Communication Responsibilities
Market Dynamics
- Market Trends
- Market Drivers
- Market Restraints
- Pricing Analysis
- Demand Analysis
- Revenue Forecasts
Competitive Analysis
- Marketing Engineering Analysis
- Competitive Structure
Market Engineering Awards
- Business Development Strategy Award
- Brand Awareness Development Award
- Product Innovation Strategy Award
- Product Line Strategy Award
- Technology Innovation Award
Market Overview
Competitive Analysis
Market Overview
Competitive Analysis
Market Overview
Competitive Analysis
Market Overview
Competitive Analysis
Market Overview
Competitive Analysis
Popular Topics
The U.S. Critical Care Antibiotics Markets report covers the various injectable antibiotics that are currently available and used in critical care in the U.S. namely, cephalosporins, quinolones, penicilliins, carbapenems and others including new classes streptogrammins and oxazolidones. The report also major pipeline critical care antibiotics. Frost & Sullivan Market Engineering Analysis, major market/technology trends, challenges, drivers and restraints and forecasts are covered on a total level and also as at the levels of the various segments. The report cites five prestigious Frost & Sullivan Market Engineering Awards to active industry participants for effective industry approaches.
| No Index | No |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | A443-01-00-00-00 |
| Is Prebook | No |